Co-Diagnostics files FDA 510(k) for flu and RSV point-of-care test
Tweet Send to a Friend
Co-Diagnostics, Inc. (Nasdaq: CODX) announced it has submitted a Dual 510(k) premarket notification to the U.S. Food and Drug Administration ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
